-
Adaptive clinical trials and their potential to improve drug-development efficiency
Christopher J Weir
Opinion Article: Clinical Investigation
-
Adaptive clinical trials and their potential to improve drug-development efficiency
Christopher J Weir
Opinion Article: Clinical Investigation
-
Adaptive clinical trials and their potential to improve drug-development efficiency
Christopher J Weir
Opinion Article: Clinical Investigation
-
Adaptive clinical trials and their potential to improve drug-development efficiency
Christopher J Weir
Opinion Article: Clinical Investigation
-
Adaptive clinical trials and their potential to improve drug-development efficiency
Christopher J Weir
Opinion Article: Clinical Investigation
-
Adaptive clinical trials and their potential to improve drug-development efficiency
Christopher J Weir
Opinion Article: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Novel adaptive designs: aligning drug development and patient incentives
John W Loewy
Commentary: Clinical Investigation
-
Novel adaptive designs: aligning drug development and patient incentives
John W Loewy
Commentary: Clinical Investigation
-
Novel adaptive designs: aligning drug development and patient incentives
John W Loewy
Commentary: Clinical Investigation
-
Novel adaptive designs: aligning drug development and patient incentives
John W Loewy
Commentary: Clinical Investigation
-
Novel adaptive designs: aligning drug development and patient incentives
John W Loewy
Commentary: Clinical Investigation
-
Novel adaptive designs: aligning drug development and patient incentives
John W Loewy
Commentary: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation
-
The IMPROVE-IT trial: current status and potential clinical implications of ezetimibe
Finn Akerstrm, Luis Rodriguez-Padial
Review Article: Clinical Investigation